trihexyphenidyl has been researched along with Hypertrophy in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nilvebrant, L | 1 |
1 review available for trihexyphenidyl and Hypertrophy
| Article | Year |
|---|---|
On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Topics: Adult; Aged; Animals; Carbachol; Cerebral Cortex; Denervation; Guinea Pigs; Humans; Hypertrophy; Ile | 1986 |